Venture Capital Investors

Good Growth Capital

VC firm Good Growth Capital provides capital to high-potential tech ventures.

Venture Investor Overview

Venture Investor
Good Growth Capital
Status
Active
Investor Type
Venture Capital
Activity Level
26 transactions
Funds Raised
Unknown
Industry Focus
Advanced Materials
Artificial Intelligence
Biopharmaceutical
Blockchain
Energy & Battery
Enterprise IT
Healthcare Services
Internet & IoT
Medical Devices & Instruments
Security
Transportation

Contact Information

Contact
Amy Salzhauer
Title
Managing Partner
Mailing Address
1505 King St. Extension
Charleston, SC 29405
USA
Phone
Undisclosed
Website
www.goodgrowthvc.com
Email Address
Not Recorded

Background Information

Overview
Good Growth Capital is a venture capital platform focused on early stage technology companies. Good Growth Capital's General Fund focuses on the east coast, filling the gap with our early-stage technology investing, with partners located in Charleston SC, Boston and NY. The fund leverages proximity to closely support our founders and connect portfolio companies to each other. Good Growth Capital's Infinite Corridor Fund is comprised of new technology startups founded by MIT students and Alumni, and focuses on industry sectors poised for rapid growth.
Profile
Good Growth Capital LinkedIn Company Profile
Social Media
Good Growth Capital Company Twitter Account
Company News
Good Growth Capital News
Facebook
Good Growth Capital on Facebook
YouTube
Good Growth Capital on YouTube
Last Transaction
4/17/2024

Transaction History

Our records indicate that Good Growth Capital invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Company
Date
Amount
Found Energy
4/17/2024
$12,000,000
Pienso
3/12/2024
$10,000,000
Base Operations
12/20/2023
$9,100,000
Eden
10/24/2023
$12,000,000
AOA Dx
10/12/2023
$17,000,000
Lemurian Labs
10/5/2023
$9,000,000
Pryon
9/19/2023
$100,000,000
VenoStent
8/1/2023
$16,000,000
Fluree
4/20/2023
$10,000,000
Orbit Fab
4/17/2023
$28,500,000
Liminal
2/6/2023
$17,500,000
AdipoPharma
1/23/2023
Unknown
Boston Materials
11/3/2022
$12,000,000
Leuko
9/23/2022
$5,000,000
Bounce Imaging
5/2/2022
$4,200,000
Liminal Insights
4/7/2022
$8,000,000
Base Operations
12/15/2021
$3,000,000
Bone Health Technologies
5/4/2021
$2,500,000
Base Operations
2/15/2021
$2,200,000
Swift Solar
12/17/2020
$8,000,000
X-Cor Therapeutics
11/13/2020
$2,600,000
Ateios
10/19/2020
$1,250,000
Fluree
9/30/2020
$6,500,000
Obsidio
8/10/2020
$3,000,000
LuminDx
7/27/2020
$2,000,000
Leuko
7/22/2019
$1,800,000

 

Investor Contacts

Title
Name
Email & Social
Partner
Milt Alpern
  Milt Alpern LinkedIn Profile  Milt Alpern Twitter Account  Milt Alpern News  Milt Alpern on Facebook
Managing Partner
Maureen Boyce
  Maureen Boyce LinkedIn Profile  Maureen Boyce Twitter Account  Maureen Boyce News  Maureen Boyce on Facebook
Partner
Igor Jablokov
  Igor Jablokov LinkedIn Profile  Igor Jablokov Twitter Account  Igor Jablokov News  Igor Jablokov on Facebook
Partner
Mark Johnson
  Mark Johnson LinkedIn Profile  Mark Johnson Twitter Account  Mark Johnson News  Mark Johnson on Facebook
Partner
Kathleen Kennedy
  Kathleen Kennedy LinkedIn Profile  Kathleen Kennedy Twitter Account  Kathleen Kennedy News  Kathleen Kennedy on Facebook
Managing Partner
Carolyne LaSala
  Carolyne LaSala LinkedIn Profile  Carolyne LaSala Twitter Account  Carolyne LaSala News  Carolyne LaSala on Facebook
Partner
David Mendez
  David Mendez LinkedIn Profile  David Mendez Twitter Account  David Mendez News  David Mendez on Facebook
Managing Partner
John Osborne
  John Osborne LinkedIn Profile  John Osborne Twitter Account  John Osborne News  John Osborne on Facebook
Managing Partner
Amy Salzhauer
  Amy Salzhauer LinkedIn Profile  Amy Salzhauer Twitter Account  Amy Salzhauer News  Amy Salzhauer on Facebook
Partner
Henry White
  Henry White LinkedIn Profile  Henry White Twitter Account  Henry White News  Henry White on Facebook

 

Funds

No fund closings have been recorded for this company.

 

Portfolio Companies

Good Growth Capital has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know.

Tech Company
AdipoPharma
AOA Dx
Ateios
Base Operations
Bone Health Technologies
Boston Materials
Bounce Imaging
Eden
Fluree
Found Energy
Lemurian Labs
Leuko
Liminal
Liminal Insights
LuminDx
Obsidio
Orbit Fab
Pienso
Pryon
Swift Solar
VenoStent
X-Cor Therapeutics

 

 

 

 

Browse more venture capital investors:

Good Games Guild | Good News Ventures

 

Share this article

 

About Our Venture Capital Investor Database

This VC firm profile is powered by VentureDeal.com, a market leader in private equity transaction data.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.